EX-23.1 3 dmtk-ex231_24.htm EX-23.1 dmtk-ex231_24.htm

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

We consent to the use of our reports dated March 10, 2022, with respect to the consolidated financial statements of DermTech, Inc., and the effectiveness of internal control over financial reporting, incorporated herein by reference.

/s/ KPMG LLP

San Diego, California

March 11, 2022